UK MHRA Aims To Cast Early Access Scheme In New Light
Agency Wants To Make EAMS More Attractive To Sponsors Of Innovative Medicines
EAMS allows promising drugs to be used in clinical practice in parallel with the later stages of the regulatory process • Source: Alamy